Symptoms of Mental Health Disorders in Critical Care Physicians Facing the Second COVID-19 Wave: A Cross-Sectional Study.

"Financial/nonfinancial disclosures:The authors have reported to CHEST the following: E. A. reports personal fees from Gilead, Baxter, Ablybx, Alexion, Pfizer, grants and nonfinancial support from Fisher & Payckle, MSD, Gilead, outside the submitted work; M. D. reports personal fees from Gilead, Astelas, MSD, grants and nonfinancial support from MSD, outside the submitted work; V. L. reports advisory board fees from Amomed unrelated with the present study; F. Barbier reports other from MSD, other from BioMérieux, outside the submitted work; L. P. reports personal fees from MSD, grants and nonfinancial support from Sedana, outside the submitted work; A. D. reports personal fees from Medtronic, grants, personal fees and nonfinancial support from Philips, personal fees from Baxter, personal fees from Hamilton, personal fees and nonfinancial support from Fisher & Paykel, grants from French Ministry of Health, personal fees from Getinge, grants, personal fees and nonfinancial support from Respinor, grants, personal fees and nonfinancial support from Lungpacer, personal fees from Lowenstein, outside the submitted work. None declared (F. P., J. R., L. A., F. Bruneel, P. C., A. C., K. K., C. G., A. K., O. G., M. J., G. V. D. M., D. R., V. S., M. R. R., and N. K. B.)."

"FUNDING/SUPPORT: This study was funded by the French Ministry of Health and sponsored by AP-HP (project AP-HP 200389)"